Sateesh Apte, M.D., a physician, formed ImmunoScience, Inc., a biotechnology company with scientists and investors to further develop and market a saliva diagnostic apparatus, a saliva based test for HIV-1 and HIV-2 (SALIVAX™) and a very exciting prod uct - a potential cure for AIDS named Contre-Vir™ . The latter is a recombinant live virus that effectively "teaches" the body's own immune system to fight the wild type AIDS virus. U.S. and International Patents are pending on the diagnostic apparatus, the HIV saliva test and the Contre-Vir™ therapeutic vaccine that has restored the immune systems of two near-death AIDS patients and made them symptom free. The pilot clinical trials of SALIVAX™-HIV have shown the test to be over 99.5% sensitive and specific when compared to the commercial ELISA and Western Blot tests. The SALIVAX™ test is far superior to any of the products currently in development or on the market.